Sign In
Free Newsletter
Jun 18, 2025
Hepion names new interim CEO, shifts to diagnostic innovation
Dr. Kaouthar Lbiati will now lead the biopharmaceutical company, which previously focused on treatments for chronic liver diseases.
Aug 1, 2024
Following restructuring, Hepion to merge with Israeli pharma firm
In December 2023, the Edison-based pharmaceutical company initiated a plan aimed at preserving capital, starting with cutting operating costs by about 60%.
Dec 8, 2023
Hepion Pharmaceuticals CEO steps down amid restructuring
In addition to cutting operational costs by about 60%, the Edison-based biopharmaceutical company is looking at options such as an acquisition or merger.
